Figure 2 | Scientific Reports

Figure 2

From: Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models

Figure 2

Effect of three months of GP1 (GPZ614741) administration. (A) Representative microphotographs and quantification of interstitial fibrosis. (B) Col I, (C) αSMA, (D) CTGF and (E) proinflammatory markers (IL6, CD68, CD80, and CD86) protein levels in Sham, MI, and MI + GP1 (GPZ614741)-treated mice. The full-length gel and bands are included in the Supplementary Fig. 11. *p < 0.05 vs. Sham. †p < 0.05 vs. MI mice.

Back to article page